Seven World Leading IT Companies to Sponsor and Speak at CHI's Adopting R&D Informatics Systems, part of 17th International Molecular Medicine Tri-Conference

Share Article

Presentations Discuss Business Strategies, Solutions, and Scientific Studies Important for the R&D Informatics Industry

Managing Research Portfolios - Can IT help you?

Cambridge Healthtech Institute is pleased to announce the participation of seven world leading IT companies at its 2nd Annual Adopting R&D Informatics Systems conference to be held on February 3-5, 2010 at the Moscone North Convention Center in San Francisco, CA. This meeting has been integrated in the Informatics Channel at CHI's flagship event, the Molecular Medicine Tri-Conference. Delegates attending this conference will hear from solution providers and collaborators that have played an essential role in integrating R&D informatics systems.

Microsoft: On Wednesday, February 3 (12:40 - 1:10 p.m.), "Personalized Medicine: The Missing Pieces" is the topic of a luncheon presentation lead by Jim Karkanias, Senior Director of Applied Research & Technology, Microsoft Health Solutions Group.

Oracle: On Thursday, February 4 (12:30 - 1:00 p.m.), Arvindh Balakrishnan, Vice President Life Sciences, Oracle & Joe Duncan, Chief Executive Officer, Teranode, talks about "Managing Research Portfolios - Can IT help you?" in a luncheon presentation.

HP: On Thursday, February 4 (1:00 - 1:30 p.m.), "SOA-based IT Framework for Life Science Research" is the topic of a luncheon presentation lead by David A. Medina, Worldwide Life Science and Pharma Segment Executive, Hewlett-Packard Company.

Accelrys: On Wednesday, February 3 (3:50 - 4:05 p.m.), Rob Brown, Ph.D., Senior Director, Informatics Marketing, Accelrys & Frank Brown, Ph.D., VP & CSO, Accelrys, will speak on "Workflow-based Enterprise Informatics."

BioFortis: On Wednesday, February 3 (1:10 - 1:40 p.m.), a representative from BioFortis will host a luncheon presentation.

Infosys: On Thursday, February 4 (10:00 - 10:15 a.m.), a representative from Infosys will host a presentation.

IDBS: On Friday, February 5 (10:05 - 10:20 a.m.), "Automating Biomarker Discovery and Qualification; Capturing Hypothesis, Analysis and IP" is the topic of discussion lead by Jonathan Sheldon, Ph.D., Director of Translational Medicine, IDBS.

Delegates, speakers, sponsors and exhibitors involved in this conference include Pharmaceutical and Biotech IT, research informatics groups and those involved with knowledge management, translational informatics and computational science with a need to know how to further the adoption of integrated R&D informatics systems and accelerate drug discovery. The exhibit hall is open February 3-4, with over 150 exhibitors and 3,000 attendees.

For more event details and to register, visit http://www.tri-conference.com/ird.asp

To inquire about sponsoring and/or exhibiting, please email Carol Dinerstein, dinerstein(at)healthtech(dot)com, or Jon Stroup, jstroup(at)healthtech(dot)com.

To apply for a press pass, please email Tracey Fielding, tfielding(at)healthtech(dot)com.

About Molecular Medicine Tri-Conference
Molecular Medicine Tri-Conference -- the flagship event of CHI - has built this year's event around 6 scientific channels, encompassing 11 conferences, providing attendees more learning opportunities than ever before. Featured channels include diagnostics, chemistry, informatics, biologics, cancer and executive. We're looking to provide attendees a more in depth experience into each of these six areas of research and development. As the need for better information, new technologies, improved strategies and competitive intelligence becomes ever more acute, this event provides compelling research insight into the future of molecular medicine. In 2010, we expect close to 3,000 attendees, 1200 participating companies, 150 exhibitors, 100 posters, and representatives from over 38 countries. http://www.Tri-Conference.com

About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI's portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech's Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. http://www.chicorporate.com

For more information:
James Prudhomme
Cambridge Healthtech Institute
(781) 972-5486
jprudhomme(at)healthtech(dot)com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tracey Fielding
Visit website